Cite Filings / MDGL / 0000950170-25-008922

Feed Companies Filings Check

Sign in

144

Sale of Securities

MADRIGAL PHARMACEUTICALS, INC. Filed 2025-01-24 Acc 0000950170-25-008922

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-01-27 4 Chief Commercial Officer sold 347 shares at $335.24 ($116,328)
2025-01-27 4 President and CEO sold 1,584 shares at $335.24 ($531,020)
2025-01-27 4 Pres., R&D, and CMO sold 648 shares at $335.24 ($217,236)
2025-01-24 144 Sale of Securities
2025-01-24 144 Sale of Securities
2025-01-24 144 Sale of Securities
2025-01-24 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…